Flavonoids are plant secondary metabolites that are well known for their health-promoting properties as nutraceuticals in diets. Bioavailability and biological activities of flavonoids vary among the individual subclasses with different patterns of substitution, inclusive of glycosylation, to their basic structures. Many flavonoids exist as glycosides in plants. This study investigated the possibility of glycosylation of flavonoids through biotransformation using filamentous fungi as whole-cell biocatalysts. Microbial transformations of ten flavonoids (four flavones, four flavonols, a flavanone, and an aurone) were performed in cultures of Mucor hiemalis KCTC 26779. As a result, a flavonoid glycoside was obtained which has not been described previously. The chemical structure of this product was elucidated as 6,2′-dimethoxyflavonol-3-O-β-d-glucopyranoside by analyzing 1-dimensional and 2-dimensional-nuclear magnetic resonance spectral and high-resolution electrospray ionization mass spectral data. This compound could be useful for further biological and bioavailability studies, as well as expanding the library of flavonoid derivatives.
Flavonoids, found in fruits, vegetables, grains, roots, flowers, tea, and wine, have been shown to possess biological activities that vary due to the diversity of their phenolic structures.1-3 Reported pharmacological activities of flavonoids include antioxidant,4,5 anti-inflammatory,6 cardioprotective,7 anticancer,8,9 antiallergic,10 and antidiabetic effects.11,12 Because of the health-promoting and pharmacological effects of flavonoids, these compounds are utilized in food technology, as supplements, and by the pharmaceutical industries.13 However, most flavonoids are unsatisfactory in terms of water solubility and stability in certain media, resulting in low absorption.14 To overcome these problems, the glycosylation or hydroxylation of flavonoids is a well-known method that can improve solubility, intracellular and intercellular transport, chemical stability, and bioactivity.7,14-17 The solubility and stability of flavonoids can be improved by structural modification using chemical methods, biocatalysts, and biotransformation.18,19
Microbial biotransformation is extensively used to transform many compounds, including hydrocarbons and pharmaceutical substances.20 It has the potential to generate chemoselective, regioselective, and stereoselective compounds under milder conditions than those used in chemical synthesis.21 Microbial biotransformation has been used for hydroxylation, dehydroxylation, O-methylation, O-demethylation, glycosylation, deglycosylation, dehydrogenation, and hydrogenation.22,23 Therefore, it is able to produce novel bioactive compounds and enhance physicochemical and pharmacological properties.24 Microbial biotransformation also has the advantage of being cost-effective, environmentally friendly, producing high yields and significant amounts of metabolites.25
In our previous study on Coreopsis lanceolata, several types of flavonoids were isolated as flavone, flavonol, flavanone, chalcones, and aurone.26 As part of our search for new derivatives and/or enhancers of bioactivity and bioavailability through microbial transformation, we performed biotransformations of isolates 1 and 2 from C. lanceolata and commercially available compounds (3-10) with similar structures to those isolated, in cultures of Mucor hiemalis KCTC 26779, which has been an efficient biocatalyst for microbial glycosylation in our studies.27-29 As a result, one compound (8) was successfully converted into a new metabolite (11) by the microbial transformation (Figure 1).
Biotransformation of 8 by Mucor hiemalis KCTC 26779.
Results and Discussion
Compound 11 was obtained as a brown solid and gave a molecular ion peak at m/z 483.1448 [M + Na]+ in its high-resolution electrospray ionization-mass spectrum (HR-ESI-MS), corresponding to an elemental formula of C23H24O10Na. The 1H and 13C-nuclear magnetic resonance (NMR) spectra of 11 were similar to those of 6,3′-dimethoxyflavonol and peterin,30,31 except for the difference in signals of the sugar moiety. The differences between the NMR spectroscopic data of the aglycone of 11 and 6,3′-dimethoxyflavonol were in the signals of the B-ring.30 On the other hand, the C-ring pattern was different between the aglycone of 11 and peterin.31 In the 1H-NMR spectrum of 11, the signals at δH 7.59 (1H, d, J = 9.2 Hz, H-8), 7.45 (1H, d, J = 3.0 Hz, H-5), and 7.38 (1H, dd, J = 9.2, 3.0 Hz, H-7) showed a 1,3,4-trisubstituted B ring system in the flavonol moiety. In addition, a 1,2-disubstituted C-ring was evident with signals at 7.70 (1H, dd, J = 7.6, 1.7 Hz, H-6′), 7.48 (1H, br t, J = 8.3 Hz, H-4′), 7.12 (1H, dd, J = 8.3, 1.0 Hz, H-3′), and 7.00 (1H, td, J = 7.6, 1.0 Hz, H-5′). The position of two methoxyl groups were assigned to C-6 and C-2′ by the correlations of two methyl proton signals at δH 3.86 (3H, s, OCH3) and 3.74 (3H, s, OCH3) with two quaternary carbon signals at δC 156.9 (C-6) and 157.7 (C-2′), respectively, in the 1H-13C heteronuclear multiple bond correlation (HMBC) spectrum of 11. In the 13C-NMR spectrum of 11, signals for a carbonyl carbon at δC 173.7 (C-4), three oxygenated aromatic carbons at δC 157.3 (C-2), 150.5 (C-9), and 137.2 (C-3), and a quaternary carbon at δC 124.8 (C-10) were observed. The 1H-13C HMBC of H-7/C-9, H-5/C-4, C-9, and H-6′/C-2 indicated that the B ring was linked to C-9 and C-10, and the C-ring to C-2, in a 3-hydroxypyran-4-one ring. Accordingly, the aglycone moiety of 11 was identified as 6,2′-dimethoxyflavonol, for which there has been no report on its NMR data so far. The sugar moiety was identified by the 1H and 13C signals at δH 2.98 (1H, m, H-5″)/δC 77.8 (C-5″), 3.12 (1H, m, H-3″)/76.9 (C-3″), 2.86 (1H, m, H-2v)/74.5 (C-2″), 2.98 (1H, m, H-4″)/70.2 (C-4″), and 3.35 (1H, d, J = 11.3 Hz, H-6a″) and 3.53 (1H, d, J = 11.3 Hz, H-6b″)/61.4 (C-6″), and the 1H-1H COSY correlations of H-2″/H-1″, H-3″, H-3″/H-2″, H-4″, and H-5″/H-6″a. The sugar moiety was determined as β-d-glucopyranose by the anomeric proton at δH 5.22, with a large coupling constant, J = 7.8 Hz, and by the 1H -1H nuclear Overhauser effect spectroscopy correlations of H-3″/H-1″ and H-5″ and H-2″/H-4″. The 1H-13C HMBC NMR correlations of H-1″/C-3 indicated that the β-d-glucopyranose was positioned at C-3 in the structure of 11 (Figure 2). Therefore, metabolite 11 was elucidated as 6,2′-dimethoxyflavonol-3-O-β-d-glucopyranoside, which has not been previously described.
Key heteronuclear multiple bond correlation (→), correlation spectroscopy (▬), and nuclear Overhauser effect spectroscopy (↔) correlations of compound 11.
In this study, the microbial transformation was attempted for a number of compounds with hydroxyl and/or methoxyl groups at diverse positions in flavone and flavonol structures. Among them, only compound 8, in which a methoxyl group was substituted for each of the A-ring and B-ring of flavonol was successfully glucosylated by M. hiemalis KCTC 26779. Other compounds (1-7, 9, and 10), with structures in which only hydroxyl groups are substituted, thus differing from compound 8, did not undergo biotransformation in this study. However, in the previous reports on microbial transformation using this microorganism,27-29 flavonoids such as quercetin, apigenin, naringenin, and prenylated flavonoids have been glycosylated.
Many natural compounds are discovered in nature in the form of glycosides and they show a broad spectrum of benefits for human health. Almost all natural flavonoids are present in plants as either their O-glycosides or C-glycosides. These glycosylated flavonoids have been reported to have greater bioactivity, solubility, stability, and/or bioavailability than their aglycones. For example, the solubility of 5-O-α-d-glucopyranosyl-(+)-catechin and 4′-O-α-d-glucopyranosyl-(+)-catechin were increased by more than 40 times and had better thermal stability than their aglycone, catechin.32 In the 2,2-diphenyl-1-picrylhydrazyl radical scavenging test, xanthohumol had a half-maximal inhibitory concentration value of 1.98 µM, while the value for xanthohumol-4′-O-β-d-glucopyranoside was 0.77 µM, indicating that the glycosylated compound had more than twice the antioxidant effect of its aglycone.33 Puerarin-7-O-fructoside had increased antioxidant activity and enhanced water solubility than puerarin.34 It has also been reported that compared with puerarin, puerarin-7-O-glucoside has higher concentrations in plasma and a longer residence time in blood.35 Based on these studies, it is speculated that the new metabolite 11 could also have enhanced bioactivity, solubility, and bioavailability. However, additional studies of this compound are required, such as biological evaluation and water solubility test.
Conclusions
In conclusion, microbial transformation studies of 10 compounds with flavonoid structures with different substituents were carried out with M. hiemalis, and only 6,2′-dimethoxy-flavonol (8) was transformed into a novel metabolite, 6,2′-dimethoxyflavonol-3-O-β-d-glucopyranoside (11). Biotransformation using M. hiemalis KCTC 26779 is a relatively easy, economic, and eco-friendly method to produce glycosylated flavonoids, which allows the products to be obtained in quantities required for further studies.
Experimental
General
The measurement of optical rotations was conducted on a JASCO DIP-1000 polarimeter (JASCO Co., Tokyo, Japan). One-dimensional (1D) and 2-dimensional (2D)-NMR spectra were obtained on a JNM-ECA 500 MHz NMR instrument (JEOL Ltd., Tokyo, Japan) with tetramethylsilane used as the internal standard. HR-ESI-MS were obtained on a Waters SYNAPT G2 mass spectrometer (Waters, Milford, MA, USA). Thin-layer chromatographic (TLC) analysis was performed on Kieselgel 60 F254 (Merck, Darmstadt, Germany) and Kieselgel 60 RP-18-F254S (Merck, Darmstadt, Germany). Analytical plates were visualized under ultraviolet light (254 and 365 nm) and sprayed with 10% (v/v) sulfuric acid, followed by heating at 180 °C for 2 minutes. Column chromatography (CC) was conducted using silica gel (70, 230 mesh, Merck, Darmstadt, Germany), RP-18 (YMC gel ODS-A, 12 nm, S-75 μm, YMC Co., Tokyo, Japan), and Sephadex LH-20 (GE Healthcare Bio-Sciences, Uppsala, Sweden).
Materials and Microorganism
Luteolin (1) and quercetin (2) were isolated from the dried flowers of Coreopsis lanceolata, as described in a previous study. 7,3′-Dihydroxyflavone (3), 6,4′-dihydroxyflavone (4), 3′,5′-dihydroxyflavone (5), and 6,2′-dimethoxyflavonol (8) were purchased from Sigma-Aldrich (St Louis, MO, USA); galangin (6), (2S)-isookanin (9), and sulfuretin (10) from Wuhan ChemFaces Biochemical Co., Ltd. (Hubei, China); and resokaempferol (7) from Extrasynthese (Genay, France). Mucor hiemalis 26779 was obtained from the Korean Collection for Type Cultures (KCTC). The ingredients for microbial media, including dextrose, peptone, and malt extract, were purchased from Becton, Dickinson and Company (Sparks, MD, USA). Mucor hiemalis was cultured on malt medium (malt extract 20 g/L, dextrose 20 g/L, peptone 1 g/L).
Screening Procedures
Microbial biotransformation studies were performed according to the standard two-stage procedure.36 The actively growing microbial cultures were inoculated in 250 mL flasks containing 50 mL of malt medium and incubated with gentle agitation (200 rpm) at 25 °C in a temperature-controlled shaking incubator. After inoculation for 24 hours, the dimethylsulfoxide (DMSO) solutions (1.5 mg/200 µL) of 1-10 were added to each flask, and the incubation was continued under the same conditions for another 7 days. Sampling and TLC monitoring were performed at an interval of 24 hours. Culture controls consisted of fermentation cultures in which the microorganisms were grown without the addition of 1-10.
Scale-Up Fermentations of 8
Preparative scale-up fermentations were carried out in three 500 mL flasks each containing 150 mL of malt medium, and each 15 mg of 8, dissolved in DMSO, distributed evenly among the flasks. After incubation for 7 days, the microbial culture broth was extracted with ethyl acetate (EtOAc, 400 mL × 3), and the organic layers were combined and concentrated in vacuo. The EtOAc extract (263 mg) of 8 from M. hiemalis culture broth was subjected to silica gel CC with a solvent system of dichloromethane-methanol (9:1 to 0:1, v/v) to produce metabolite 11 (12 mg).
HR-ESI-MS: m/z 483.1448 [M + Na]+ (calcd. for C23H26O10Na, 483.1267).
Footnotes
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Grants from Radiation Technology R&D program (No. 2017M2A2A6A05018541) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning.
ORCID iD
Bo-Ram Kim
References
1.
PancheAN.DiwanAD.ChandraSR. Flavonoids: an overview. J Nutr Sci. 2016;5(47):1-15.doi:10.1017/jns.2016.41
2.
PetersonJ.DwyerJ. Flavonoids: dietary occurrence and health benefits. Spatula DD. 2012;2(1):59-68.
3.
WiczkowskiW.PiskulaM. Food flavonoids. Pol J Food Nutr Sci. 2004;54:101-114.
4.
MengX-H.LiuC.FanRet al. Antioxidative flavan-3-ol dimers from the leaves of Camellia fangchengensis. J Agric Food Chem. 2018;66(1):247-254.doi:10.1021/acs.jafc.7b04572http://www.ncbi.nlm.nih.gov/pubmed/29232949
5.
EscricheI.KadarM.Juan-BorrásM.DomenechE. Suitability of antioxidant capacity, flavonoids and phenolic acids for floral authentication of honey. impact of industrial thermal treatment. Food Chem. 2014;142:135-143.doi:10.1016/j.foodchem.2013.07.033http://www.ncbi.nlm.nih.gov/pubmed/24001823
6.
LiH.DengZ.LiuR.LoewenS.TsaoR. Bioaccessibility, in vitro antioxidant activities and in vivo anti-inflammatory activities of a purple tomato (Solanum lycopersicum L.). Food Chem. 2014;159:353-360.doi:10.1016/j.foodchem.2014.03.023http://www.ncbi.nlm.nih.gov/pubmed/24767066
7.
WangA.ZhangF.HuangLet al. New progress in biocatalysis and biotransformation of flavonoids. J Med Plant Res. 2010;4(10):847-856.
8.
SantosIS.PonteBM.BoonmeP.SilvaAM.SoutoEB. Nanoencapsulation of polyphenols for protective effect against colon-rectal cancer. Biotechnol Adv. 2013;31(5):514-523.doi:10.1016/j.biotechadv.2012.08.005http://www.ncbi.nlm.nih.gov/pubmed/22940401
9.
AhmedSI.HayatMQ.TahirMet al. Pharmacologically active flavonoids from the anticancer, antioxidant and antimicrobial extracts of Cassia angustifolia Vahl. BMC Complement Altern Med. 2016;16(1):460.doi:10.1186/s12906-016-1443-zhttp://www.ncbi.nlm.nih.gov/pubmed/27835979
LiuY-J.ZhanJ.LiuX-L.WangY.JiJ.HeQ-Q. Dietary flavonoids intake and risk of type 2 diabetes: a meta-analysis of prospective cohort studies. Clin Nutr. 2014;33(1):59-63.doi:10.1016/j.clnu.2013.03.011http://www.ncbi.nlm.nih.gov/pubmed/23591151
12.
XiaoJ.KaiG.YamamotoK.ChenX. Advance in dietary polyphenols as α-glucosidases inhibitors: a review on structure-activity relationship aspect. Crit Rev Food Sci Nutr. 2013;53(8):818-836.doi:10.1080/10408398.2011.561379http://www.ncbi.nlm.nih.gov/pubmed/23768145
13.
KostrzwaSE.JaneczkoT. Microbial transformation of 7-hydroxyflavanone. Sci World J. 2012;254929(4):1-8.
14.
DymarskaM.JaneczkoT.Kostrzewa-SusłowE. Glycosylation of methoxylated flavonoids in the cultures of Isaria fumosorosea KCH J2. Molecules. 2018;23(10):2578.doi:10.3390/molecules23102578http://www.ncbi.nlm.nih.gov/pubmed/30304815
15.
HoferB. Recent developments in the enzymatic O-glycosylation of flavonoids. Appl Microbiol Biotechnol. 2016;100(10):4269-4281.doi:10.1007/s00253-016-7465-0http://www.ncbi.nlm.nih.gov/pubmed/27029191
16.
OlthofMR.HollmanPC.VreeTB.KatanMB. Bioavailabilities of quercetin-3-glucoside and quercetin-4′-glucoside do not differ in humans. J Nutr. 2000;130(5):1200-1203.doi:10.1093/jn/130.5.1200http://www.ncbi.nlm.nih.gov/pubmed/10801919
WangA.ZhangF.HuangLet al. New progress in biocatalysis and biotransformation of flavonoids. J Med Plant Res. 2010;4(10):847-856.
19.
HaddadAQ.VenkateswaranV.ViswanathanL.TeahanSJ.FleshnerNE.KlotzLH. Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines. Prostate Cancer Prostatic Dis. 2006;9(1):68-76.doi:10.1038/sj.pcan.4500845http://www.ncbi.nlm.nih.gov/pubmed/16314891
20.
MutafovaB.MutafovS.FernandesP.BerkovS. Microbial transformations of plant origin compounds as a step in preparation of highly valuable pharmaceuticals. J Drug Metab Toxicol. 2016;7(2):1000204.doi:10.4172/2157-7609.1000204
21.
BhattiHN.ZubairM.RasoolN.HassanZ.AhmadVU. Microbial transformation of sesquiterpenoids. Nat Prod Commun. 2009;4(8):1155-1168.doi:10.1177/1934578X0900400828http://www.ncbi.nlm.nih.gov/pubmed/19769003
22.
CaoH.ChenX.JassbiAR.XiaoJ. Microbial biotransformation of bioactive flavonoids. Biotechnol Adv. 2015;33(1):214-223.doi:10.1016/j.biotechadv.2014.10.012http://www.ncbi.nlm.nih.gov/pubmed/25447420
23.
XuJ-Q.FanN.YuB-Y.WangQ-Q.ZhangJ. Biotransformation of quercetin by Gliocladium deliquescens NRRL 1086. Chin J Nat Med. 2017;15(8):615-624.doi:10.1016/S1875-5364(17)30089-4http://www.ncbi.nlm.nih.gov/pubmed/28939024
24.
BartmańskaA.TroninaT.PopłońskiJ.HuszczaE. Biotransformations of prenylated hop flavonoids for drug discovery and production. Curr Drug Metab. 2013;14(10):1083-1097.doi:10.2174/1389200214666131211151855http://www.ncbi.nlm.nih.gov/pubmed/24329115
25.
DouF.WangZ.LiG.DunB. Microbial transformation of flavonoids by Isaria fumosorosea ACCC 37814. Molecules. 2019;24(6):1028.doi:10.3390/molecules24061028http://www.ncbi.nlm.nih.gov/pubmed/30875913
26.
KimB-R.PaudelSB.NamJ-W.JinCH.LeeI-S.HanA-R. Constituents of Coreopsis lanceolata flower and their dipeptidyl peptidase IV inhibitory effects. Molecules. 2020;25(19):4370.doi:10.3390/molecules25194370http://www.ncbi.nlm.nih.gov/pubmed/32977609
27.
XiaoY.LeeI-S. Microbial transformation of naringenin derivatives. Arch Pharm Res. 2017;40(6):720-726.doi:10.1007/s12272-017-0916-zhttp://www.ncbi.nlm.nih.gov/pubmed/28612118
28.
HanF.XiaoY.LeeI-S. Microbial transformation of prenylquercetins by Mucor hiemalis. Molecules. 2020;25(3):528.doi:10.3390/molecules25030528http://www.ncbi.nlm.nih.gov/pubmed/31991807
29.
XiaoY.LeeI-S. Microbial metabolism of prenylated apigenin derivatives by Mucor hiemalis. Phytochem Lett. 2016;16:197-202.doi:10.1016/j.phytol.2016.04.018
30.
KimH.MoonB-H.AhnJ-H.LimY. Complete NMR signal assignments of flavonol derivatives. Magn Reson Chem. 2006;44(2):188-190.doi:10.1002/mrc.1733http://www.ncbi.nlm.nih.gov/pubmed/16358292
OchiaiM.FukamiM.Nakao AN. Method of glycosylation of flavonoid compounds. United States patent Appllication publication PUB. No.: US2010/0256345 A1.
33.
TroninaT.BartmańskaA.MilczarekMet al. Antioxidant and antiproliferative activity of glycosides obtained by biotransformation of xanthohumol. Bioorg Med Chem Lett. 2013;23(7):1957-1960.doi:10.1016/j.bmcl.2013.02.031http://www.ncbi.nlm.nih.gov/pubmed/23466227
34.
WangS.LiuG.ZhangWet al. Efficient glycosylation of puerarin by an organic solvent-tolerant strain of Lysinibacillus fusiformis. Enzyme Microb Technol. 2014;57(57):42-47.doi:10.1016/j.enzmictec.2014.01.009http://www.ncbi.nlm.nih.gov/pubmed/24629266
35.
JiangJ.YuanS.DingJet al. Conversion of puerarin into its 7-O-glycoside derivatives by Microbacterium oxydans (CGMCC 1788) to improve its water solubility and pharmacokinetic properties. Appl Microbiol Biotechnol. 2008;81(4):647-657.doi:10.1007/s00253-008-1683-zhttp://www.ncbi.nlm.nih.gov/pubmed/18795283
36.
ClarkAM.McChesneyJD.HuffordCD. The use of microorganisms for the study of drug metabolism. Med Res Rev. 1985;5(2):231-253.doi:10.1002/med.2610050203http://www.ncbi.nlm.nih.gov/pubmed/3887066